House Republicans use FDA appropriations bill to override REMS changes on abortion pill
The Republican-led House Appropriations Committee on Wednesday advanced the 2024 FDA spending bill by a 34-27 vote after Democrats failed to remove language in the bill that would nullify changes the FDA made to the risk evaluation and mitigation strategy (REMS) for the abortion pill mifepristone in January.
Those FDA changes had eased access to mifepristone by allowing certain pharmacies to dispense the pill, which is used in combination with another medicine to end early pregnancies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.